heparin: be used for myocardial infarction

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.72
, blood
Weight: 0.57
, agent
Weight: 0.56
, molecule
Weight: 0.56
Siblings acetaminophen
Weight: 0.37
, fentanyl
Weight: 0.37
, warfarin
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be used for myocardial infarction 1.00
be used for infarction 0.93
induced thrombocytopenia cause thrombosis 0.81
contraindicated in subarachnoid hemorrhage 0.79
be used in cardiac surgery 0.79
be contraindicated in endocarditis 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.51
Similarity weight: 0.76
Evidence: 0.65
¬ Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.76
¬ Remarkable(warfarin, be contraindicated in endocarditis)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.76
Remarkable(warfarin, be contraindicated in endocarditis)
Evidence: 0.82
¬ Plausible(warfarin, be contraindicated in endocarditis)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.85
¬ Salient(heparin, be used for myocardial infarction)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.93
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.74
¬ Salient(heparin, be used for infarction)
0.70
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.93
Evidence: 0.81
Typical(heparin, be used for myocardial infarction)
Evidence: 0.62
¬ Typical(heparin, be used for infarction)
0.68
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.93
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.63
¬ Plausible(heparin, be used for infarction)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.81
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.93
¬ Salient(heparin, induced thrombocytopenia cause thrombosis)
0.59
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.93
Evidence: 0.65
Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.71
¬ Remarkable(heparin, be used for infarction)
0.59
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.79
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.83
¬ Salient(heparin, be used in cardiac surgery)
0.59
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.79
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.88
¬ Salient(heparin, contraindicated in subarachnoid hemorrhage)
0.58
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.81
Evidence: 0.81
Typical(heparin, be used for myocardial infarction)
Evidence: 0.86
¬ Typical(heparin, induced thrombocytopenia cause thrombosis)
0.57
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.79
Evidence: 0.81
Typical(heparin, be used for myocardial infarction)
Evidence: 0.81
¬ Typical(heparin, be used in cardiac surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.79
Evidence: 0.81
Typical(heparin, be used for myocardial infarction)
Evidence: 0.81
¬ Typical(heparin, contraindicated in subarachnoid hemorrhage)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.89
¬ Salient(heparin, be contraindicated in endocarditis)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.84
¬ Plausible(heparin, induced thrombocytopenia cause thrombosis)
0.56
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.79
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.76
¬ Plausible(heparin, be used in cardiac surgery)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.79
¬ Plausible(heparin, contraindicated in subarachnoid hemorrhage)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.81
Typical(heparin, be used for myocardial infarction)
Evidence: 0.78
¬ Typical(heparin, be contraindicated in endocarditis)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.78
¬ Plausible(heparin, be contraindicated in endocarditis)
0.53
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.65
Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.61
¬ Remarkable(heparin, be used in cardiac surgery)
0.52
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.81
Evidence: 0.65
Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.71
¬ Remarkable(heparin, induced thrombocytopenia cause thrombosis)
0.51
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.79
Evidence: 0.65
Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.69
¬ Remarkable(heparin, contraindicated in subarachnoid hemorrhage)
0.48
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.76
Evidence: 0.65
Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.85
Salient(heparin, be used for myocardial infarction)
Evidence: 0.81
¬ Typical(heparin, be used for myocardial infarction)
Evidence: 0.65
¬ Remarkable(heparin, be used for myocardial infarction)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.77
Plausible(heparin, be used for myocardial infarction)
Evidence: 0.81
¬ Typical(heparin, be used for myocardial infarction)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.47
Similarity weight: 0.76
Evidence: 0.65
¬ Remarkable(heparin, be used for myocardial infarction)
Evidence: 0.82
¬ Typical(warfarin, be contraindicated in endocarditis)